Table 2.

Clinicopathologic features and galanin expression in colon cancer

Clinicopathologic featureVariableNo. casesGalanin expression (ng/mL)P
Age (y)<602539.7 ± 14.2NS
≥604142.4 ± 21.4
SexMale2641.0 ± 18.9NS
Female4041.7 ± 19.1
Tumor size (mm)<602726.9 ± 14.6<60 and ≥60, <0.001
≥604151.4 ± 14.8Control* and <60, NS
Control* and ≥60, <0.001
Duke's stageA1330.5 ± 18.3A and C, 0.002
B2331.4 ± 14.9A and D, 0.005
C1154.0 ± 16.3B and C, 0.007
D1953.6 ± 12.9B and D, <0.001
Control* and A, NS
Control* and B, NS
Control* and C, <0.001
Control* and D, <0.001
MetastasisM04740.6 ± 20.50.28
M11943.3 ± 14.5
  • Abbreviation: NS, not significant.

  • * Galanin expression in control healthy donors is 25.6 ± 14.5.